Tag: Flowonix
ADDRESS trial of Prometra II infusion system begins
The first patients have been implanted with the Prometra II Programmable Infusion System in the ADDRESS (Australian direct drug administration for refractory epilepsy)clinical trial at...
Flowonix Medical announces first use of its Patient Therapy Controller
The first patients to benefit from Flowonix Medical’s newly Food and Drug Administration-approved Patient Therapy Controller (PTC) have received the device. W Porter McRoberts...
Flowonix Medical Patient Therapy Controller receives FDA approval
Flowonix Medical’s newest product, the Patient Therapy Controller (PTC), has been approved for US market release by the Food and Drug Administration. The PTC...
Flowonix Medical and Alliance Spine and Pain Centers announce first Prometra...
Flowonix Medical and Alliance Spine and Pain Centers have announced the first implant of the Prometra II intrathecal infusion pump in Georgia, USA. The...
Flowonix Medical announces first implants of Prometra II
Flowonix Medical has announced that the first implants of its Prometra II intrathecal infusion pump took place on 5 May, 2015 at St Francis Hospital in Charleston, USA.
